Growth hormone in inflammatory bowel disease

European Review for Medical and Pharmacological Sciences

Volumn 10, Issue 1, 2006, Pages 13-16

  De Pascalis, B ^a   Bianchi, A ^a   Satta, M A ^a   Lupascu, A ^a   Mentella, M C ^a   Leo, D ^a   Fiore, F ^a   Fedeli, P ^a   Pontecorvi, A ^a   Pola, P ^a   Melina, D ^a   Gasbarrini, A ^a   De Marinis, L ^a   Armuzzi, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Growth hormone insulin like growth factor I axis; Inflammatory bowel disease; Infliximab

Indexed keywords

COLLAGEN; CYTOKINE; GROWTH HORMONE; INFLIXIMAB; INTERLEUKIN 6; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ARTICLE; CATABOLISM; CELL KINETICS; CHRONIC INFLAMMATION; CLINICAL TRIAL; CROHN DISEASE; DATA ANALYSIS; DRUG EFFICACY; ENTERITIS; EPITHELIUM CELL; HORMONE RESISTANCE; HUMAN; IMMUNOMODULATION; IN VIVO STUDY; INFLAMMATORY CELL; INTESTINE MUCOSA; MALNUTRITION; NONHUMAN; ULCERATIVE COLITIS;

ANIMALS; ANTIBODIES, MONOCLONAL; DRUG RESISTANCE; GROWTH HORMONE; HUMANS; INFLAMMATORY BOWEL DISEASES; INSULIN-LIKE GROWTH FACTOR I; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33644536425     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417-429.
2. Matthes H, Herbst H, Schuppan D, Stallmach A, Milani S, Stein H, Riecken EO. Cellular localization of procollagen gene transcripts in inflammatory bowel diseases. Gastroenterology 1992; 102: 431-442.
3. Pucilowska JB, Williams KL, Lund PK. Fibrogenesis: IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models. Am J Physiol Gastrointest Liver Physiol 2000; 279: G653-G659.
4. Pucilowska JB, McNaughton KK, Mohapatra NK, et al. IGF-I and procollagen alphal 1 (I) are coexpressed in a subset of mesenchymal cells in active Crohn's disease. Am J Physiol Gastrointest Liver Physiol 2000; 279: G 1 307-G 1322.
5. McLeod RS. Surgery for inflammatory bowel diseases. Dig Dis 2003; 21: 168-179.
6. Theiss AL, Fruchtman S, Lund K. Growth factors in inflammatory bowel disease. Inflamm Bowel Dis 2004; 10: 871-880.
7. Mauras N, George D, Evans J, et al. Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study. Metabolism 2002; 51: 127-135.
8. Seguy D, Vahedi K, Kapel N, et al. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study. Gastroenterology 2003; 124: 293-302.
9. Slonim AE, Bulone L, Damore MB, et al. A preliminary study of growth hormone therapy for Crohn's disease. N Engl J Med 2000; 342: 1633-1637.
10. Bernstein CN, Blanchard JF, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 2001; 91: 854-862.
11. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001; 131: 3109S-3120S.
12. Seidman E, Leleiko N, Ament M, et al. Nutritional issues in paediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1991; 12: 424-438.
13. Goh J, O'Morain CA. Nutrition and adult inflammatory bowel disease. Aliment Pharmacol Ther 2003; 17: 307-320.
14. Ballinger A. Fundamental mechanisms of growth failure in inflammatory bowel disease. Horm Res 2002; 58 (Suppl 1): 7-10.
15. Rechler MM. Insulin-like growth factor binding proteins. Vitam Horm 1993; 47: 1-114.
16. Silva CM, Lu H, Day RN. Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone. Mol Endocrinol 1996; 10: 508-518.
17. Woelfle J, Billiard J, Rotwein P. Acute control of insulin-like growth factor-I gene transcription by growth hormone through Stat5b. J Biol Chem 2003; 278: 22696-22702.
18. Canani RB, Bisceglia M, Bruzzese E, et al. Growth hormone stimulates, through tyrosine kinase, on transport and proliferation in human intestinal cells. J Pediatr Gastroenterol Nutr 1999; 28: 315-320.
19. Miller ME, Michaylira CZ, Simmons JG, Ney DM, Dahly EM, Heath JK, Lund PK. Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation. Gastroenterology 2004; 127: 570-581.
20. Waitzberg DL, Cukier C, Mucerino DR, et al. Small bowel adaptation with growth hormone and glutamine after massive resection of rat's small bowel. Nutr Hosp 1999; 14: 81-90.
21. Ulshen MH, Dowling RH, Fuller CR, et al. Enhanced growth of small bowel in transgenic mice overexpressing bovine growth hormone. Gastroenterology 1993; 104: 973-980.
22. Ballinger AB, Camacho-Hubner C, Croft NM. Growth failure and intestinal inflammation. QJM 2001; 94: 121-125.
23. Williams KL, Fuller CR, Dieleman LA, et al. Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone. Gastroenterology 2001; 120: 925-937.
24. Powell DW, Mifflin RC, Valentich JD, et al. Myofibroblasts: II. Intestinal subepithelial myofibroblasts. Am J Physiol 1999; 277: C183-C201.
25. Theiss AL, Fuller CR, Liu B, et al. Growth hormone reduces the severity of fibrosis associated with chronic intestinal inflammation. Gastroenterology 2004; 126: A-82.
26. Kuemmerle JF, Zhou H, Bowers JG. IGF-I stimulates human intestinal smooth muscle cell growth by regulation of G1 phase cell cycle proteins Am J Physiol Gastrointest Liver Physiol 2004; 286: G412-G419.
27. Simmons JG, Pucilowska JB, Lund PK. Autocrine and paracrine actions of intestinal fibroblast-derived insulin-like growth factors. Am J Physiol 1999; 276: G817-G827.
28. Lawrance IC, Maxwell L, Doe W. Inflammation location, but not type, determines the increase in TGF-beta1 and IGF-1 expression and collage deposition in IBD intestine. Inflamm Bowel Dis 2001; 7: 16-26.
29. Ballinger AB, Azooz O, El-Haj T, et al. Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut 2000; 46: 694-700.
30. Armuzzi A, Bianchi A, De Pascalis B, et al. Effect of infliximab on growth hormone dynamic in adult Crohn's disease. Gut 2005; 54 (Suppl 7): A153.
31. Colasanti S, Lupascu A, Satta MA, et al. TNF-alpha inhibitors and growth hormone (GH) secretion. Proceedings of the Endocrine Society 2004: P1-411.
32. Vespasiani Gentilucci U, Caviglia R, Picardi A, et al. Infliximab reverses growth hormone resistance associated with inflammatory bowel disease. Aliment Pharmacol Ther 2005; 21: 1063-1071.
33. Rutgeerts P, Van Assche G, Vermeire S. Optimizing anti-TNF treatment in inflammatory bowel disease. Gastroenterology 2004; 126: 1593-1610.
34. Armuzzi A, De Pasacalis B, Lupascu A, Fedeli P, Leo D, Mentella MC, Vincenti F, Melina D, Gasbarrini G, Pola P, Gasbarrini A. Infliximab in the treatment of steroid-dependent ulcerative colitis. Eur Rev Med Pharmacol Sci 2004;8: 231-233.
35. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005; 353: 2462-2476.